NCT04264351

Brief Summary

Objectives: To assess the prevalence of frailty in patients older than 70 y/o in nephrourologic surgery. To study if preoperative frailty is an independent predictor of immediate postoperative complications, after 30 days, 6 months and 1 year of follow-up. To detect if there are other independent risk factors for complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
413

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

January 3, 2019

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

February 11, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

September 18, 2023

Status Verified

September 1, 2023

Enrollment Period

4.1 years

First QC Date

January 3, 2019

Last Update Submit

September 15, 2023

Conditions

Keywords

FrailtyAnesthesiacomplications

Outcome Measures

Primary Outcomes (2)

  • Frailty as a risk factor of postoperative events.

    Assessment the prevalence of frailty in the surgical settings defined as a clinically recognizable state of increased vulnerability resulting from aging-associated decline in reserve and function across multiple physiologic systems. Frailty is defined as meeting three out of five phenotypic criteria indicating compromised energetics: low grip strength, low energy, slowed waking speed, low physical activity, and/or unintentional weight loss

    2017-2021

  • Frailty will be evaluated during the preoperative visit of patients 70+ scheduled to uronephrologic surgery

    Frailty is going to be evaluated in the anesthetic preoperative visit using the Short Physical Performance Battery (SPPB), Canadian Frailty Scale, Mini-Cog test (Memory an executive functions), Pfeiffer Test (Cognitive global screening), Involuntary loose of more than 4,5kg or 5% of weight in the previous year, physical activity using the Metabolic Equivalents of Task (MET).

    2017-2021

Secondary Outcomes (3)

  • Postoperative events and frailty

    2017-2021

  • Mortality associated to frailty and its complications

    2017-2021

  • Preoperative visit as a chance to assess frailty

    2017-2021

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing urological scheduled surgery in our centre, that fill in the inclusion criteria with no exclusion criteria.

You may qualify if:

  • Patients who participate voluntarily
  • Signed Informed consent
  • + years old
  • Scheduled urological surgery with general or regional anesthesia and length of stay in hospital over 24 hours.
  • Patients with preserved domiciliary deambulation without aid of another person. (walking sticks, or walkers are accepted)

You may not qualify if:

  • No signing of the informed consent
  • Surgery performed with local anesthetics
  • Day surgery, extracorporeal wave lithotripsy or endourological catheterism
  • Advanced diagnosed dementia
  • Patients with chronic advanced disease or terminal oncological disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fundació Puigvert

Barcelona, 08025, Spain

Location

MeSH Terms

Conditions

Emergence DeliriumFrailty

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Sergi Sabate, MD PhD

    Chair Anesthesiologist at Fundació Puigvert

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Anesthesiology consultant

Study Record Dates

First Submitted

January 3, 2019

First Posted

February 11, 2020

Study Start

January 1, 2017

Primary Completion

February 1, 2021

Study Completion

January 1, 2023

Last Updated

September 18, 2023

Record last verified: 2023-09

Locations